Endocrine Treatment of Breast Cancer
Springer Berlin (Verlag)
978-3-642-81408-2 (ISBN)
I. Improved Biochemical Characterization of Breast Cancer.- 1. Improved Biochemical Characterization of Breast Cancer as a Guide to Hormonal Treatment.- 2. Steroid Receptor Determinations in Mammary Carcinoma in Women.- 3. Steroid Receptor Determination by Means of Agar Gel Electrophoresis.- 4. Estrogen Receptor Determination Predicts Response to Tamoxifen Therapy.- 5. Estrogen Receptor Status and the Disease-Free Interval in Breast Cancer.- 6. Clinical Predictive Criteria for Response to Endocrine Treatment and the Receptor Status.- II. Antiestrogens in Experimental Breast Cancer.- 7. Anti-Oestrogen Action in Experimental Breast Cancer.- 8. Studies on Mechanisms of Estrogen and Antiestrogen Action in Human Breast Cancer.- 9. Human Breast Cancer in Nude Mice: A Model for Testing Endocrine Treatment.- 10. A Hormone-Dependent Human Breast Cancer Cell Line Grown in Defined Medium.- 11. Endocrine and Cytostatic Treatment of Experimental Mammary Cancer.- 12. The Direct Inhibition of Prostaglandin Synthetase of Human Breast Cancer Tumour Tissue by Tamoxifen.- III. Endocrine Treatment of Advanced Breast Cancer.- 13. Endocrine Treatment of Advanced Breast Cancer.- 14. Principles and Indications of Endocrine Treatment of Advanced Breast Cancer.- 15. Ablation of the Hypophysis by Radioactive Gold in Metastatic Mammary Carcinoma.- 16. Anti-Oestrogens: An Alternative to Ablative Endocrine Therapy?.- IV. Anti-Oestrogens in the Treatment of Advanced BreastCancer.- 17. Tamoxifen in Advanced Breast Cancer: Experience of the SAKK (Schweizerische Arbeitsgruppe für Klinische Krebsforschung - Swiss Cooperative Oncology Group).- 18. Therapeutic Effect of Tamoxifen Related to Estrogen Receptor Level.- 19. Results of Tamoxifen Therapy in Patients with Breast Cancer.- 20. Results withTamoxifen in Advanced Mammary Carcinoma.- 21. The Significance of Tumour "Stimulation" by Tamoxifen.- V. Combination Therapy of Advanced Breast Cancer.- 22. Simultaneous Hormone- and Chemotherapy, Compared with Hormone Therapy Followed by Chemotherapy in the Treatment of Metastasising Mammary Carcinoma - Preliminary Results of a Current Study.- 23. Lack of Estrogen Receptor Associated with an Increased Response Rate to Cytotoxic Chemotherapy in Metastatic Breast Cancer?.- 24. The Influence of Polychemotherapeutic Regimen on the Female Endocrine Control Mechanisms in Mammary Carcinoma Patients.- 25. Therapeutic Effect of Tamoxifen Alone Versus Tamoxifen in Combination with Gestagen and Oestrogen in Advanced Breast Cancer.- VI. Adjuvant Endocrine Therapy of Breast Cancer.- 26. Is There a Place for Adjuvant Endocrine Therapy of Breast Cancer?.- 27. Adjuvant Endocrine Therapy of Breast Cancer - A Controlled Clinical Trial of Oestrogen and Anti-Oestrogen: Preliminary Results of the Copenhagen Breast Cancer Trials.- VII. Principles of Clinical Trials.- 28. Principles of Clinical Trials.- 29. Establishment of Uniformity in Steroid Receptor Analyses Used in Cooperative Clinical Trials of Breast Cancer Treatment.- VIII. Anti-Oestrogen Treatment in Breast Cancer - A Comprehensive Review.- 30. Clinical Experience with Tamoxifen in Advanced Breast Cancer.- 31. The Place of Tamoxifen in the Treatment of Breast Cancer.- Final Remarks.
Erscheint lt. Verlag | 15.12.2011 |
---|---|
Reihe/Serie | Recent Results in Cancer Research |
Zusatzinfo | XX, 228 p. 7 illus. |
Verlagsort | Berlin |
Sprache | englisch |
Maße | 170 x 244 mm |
Gewicht | 441 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Gynäkologie / Geburtshilfe |
Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
Schlagworte | Brustkrebs • Brustkrebs / Mammakarzinom • Child • Hormone • Hormone Therapy • Hormontherapie • Tamoxifenum |
ISBN-10 | 3-642-81408-5 / 3642814085 |
ISBN-13 | 978-3-642-81408-2 / 9783642814082 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich